Navigation Links
New Drug Combination is Able to Eradicate Breast Metastases in Mice
Date:12/17/2007

SAN ANTONIO, Dec. 17 /PRNewswire/ -- A novel combination of drugs was able to completely eradicate human breast metastases growing in mice, and shows promise for the effective treatment of patients with advanced metastatic breast cancer. Dr. Sophia Ran from Southern Illinois University School of Medicine presented the results of a study using nab-paclitaxel and bevacizumab to treat lymphatic and pulmonary metastases in female SCID mice.

Paclitaxel is a widely used cancer chemotherapy drug, originally derived from an extract of the yew tree. It can have severe side effects, some of which are related to the fact that it will not dissolve in water and has to be dissolved in organic solvents for injection. Nab-paclitaxel is a nanoparticle form of paclitaxel that is coated with a nonreactive protein, albumin, allowing it to be dissolved in water. This has reduced the side effects of the treatment, and also makes it more effective.

Bevacizumab is a monoclonal antibody against vascular endothelial growth factor A (VEGF-A), a protein that is involved in building new blood vessels. Tumors require new networks of blood vessels in order to grow.

The idea for this research came from the observation that, nf cells that survive treatment with chemotherapy, the stress of the treatment causes excess VEGF-A to be produced. The VEGF-A protects the cells against future chemotherapy, and also generates new blood vessels. Both mechanisms may contribute to tumor recurrence and metastatic spread following chemotherapy. This is the molecular basis for combining bevacizumab with nab-paclitaxel for the treatment of metastatic tumors.

For this study, human breast cancer cells were implanted into mammary fat pads (the mouse equivalent of breast tissue) of female mice. The implanted cells grew into tumors, and lymphatic and pulmonary metastases developed by the time that the drugs were administered.

The drug combination completely eradicated the origina
'/>"/>

SOURCE San Antonio Breast Cancer Symposium
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
2. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
3. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
4. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
5. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
6. Vion Pharmaceuticals Announces Initiation of a Phase I/II Trial of Cloretazine(R) (VNP40101M) in Combination with Temodar(R) in Adult Brain Tumors
7. New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy
8. New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients With Complicated Skin Infections, Including MRSA
9. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
10. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
11. New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients with Diabetic Foot Infections

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...v. 6 Oxygen Biotherapeut...ed that a previously approved reverse split of its...ding on Monday, Nov. 9, 2009 on a 1-for-15 split-a... will trade under the new symbol OXBT. The stock a...n the split becomes effective. ,, "This reverse...
(Date:11/6/2009)...6 Trius Therapeutics, Inc. announc...t on Form S-1 with the U.S. Securities and Exchang...public offering of shares of its common stock. All...ring will be offered by the Company. ,, Credit ...-running manager, Piper Jaffray & Co. is actin...
(Date:11/6/2009)...Nov. 6 Roper Industries...signed a definitive agreement to acquire Verathon,...evices. The Verathon Board of Directors has appro...customary regulatory approvals and closing conditi...expect the closing to be completed in early Decemb...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 2Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 3Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 2Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 3Joshua Rosenthal to Present Free Nutrition Talks in California 48166 1Joshua Rosenthal to Present Free Nutrition Talks in California 48166 2Children Uniting Nations Russell Simmons Mos Def David Archuleta Terrence Howard Gabrielle Union Vivica Fox Elise Neal and Shawn King Visit 48163 1Children Uniting Nations Russell Simmons Mos Def David Archuleta Terrence Howard Gabrielle Union Vivica Fox Elise Neal and Shawn King Visit 48163 2AccuVein and GSABC Enter into Purchasing Agreement for Vein Illumination Device 12520 1AccuVein and GSABC Enter into Purchasing Agreement for Vein Illumination Device 12520 2
...iation on Track -, BRISBANE, Australia, Aug. 16 ...PGLA) today announced it has,executed an agreement...arch,Organisation, to utilise their services for a... This agreement includes the execution of the,Phas...he treatment of,primary liver cancer (hepatocellul...
...ons on the Topic of Drug Repurposing and ...TOWN, N.J., Aug. 16 Vicus Therapeutics, Inc., an,... company, announced today,that Chief Executive Off...eric Young, Ph.D., will each present at the 234th ...ay, August 19, 2007. The Meeting is being,held at ...
Other Medicine Technology:Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88 2Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88 3Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA 2Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA 3
(Date:11/8/2009)...ire-USNewswire/ -- The American Public Health Asso...s provisions in the health reform bill passed last...ill, the House takes important steps toward univer...ms and moving our health system from one that focu...eping people healthy," said Georges C. Benjamin, M...
(Date:11/8/2009)...romotes self-assurance, research finds , ...may have been right when she told you to sit up st...uld make you feel more confident about your though...straight gives a good impression to other people,"...ology professor at Ohio State University, said in ...
(Date:11/8/2009)...of the game later, doctors say , , SUNDA...e talk of the NFL this season, sidelining such sta...lie Parker. , Officials at the American Podiatr...iatric Sports Medicine are warning athletes to tak...ke football and lacrosse. , "Many fall sports a...
(Date:11/8/2009)...e-USNewswire/ -- Speaker Nancy Pelosi and Democrat...ouse passage of H.R. 3962, the Affordable Health C... 220 to 215. Below are the Speaker,s opening rema...ived a call from the President of the United State...ory for the American people. I thank the President...
(Date:11/8/2009)...called "Preventing and Healing AIDS Through O...ws that AIDS is a result of multiple, repeated and... system stressor agents, which can be either chemi...nal. , Oakland, CA (PRWE..., cell biologists, physicians, chemists and other ...
Breaking Medicine News(10 mins):Health News:APHA Applauds Prevention and Wellness Provisions in House Health Reform Bill 2Health News:Good Posture May Inspire Confidence 2Health News:Rx for Fall Foot Injuries 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 3
... 22 Bertalan Mesko, medical blogger and health 2....rst medical web 2.0 guidance service, launched N...aining all the web tools from quality blogs and co...gs, news aggregators, wikis, forums and social med...
...rships with AmeriCares and Clorox result in quick ...wildfires, tornadoes, flooding this spring , , CH...mpany have partnered to provide bleach and cleanin...re beginning the arduous task of cleaning out thei...
...lable in French . , A discovery made by resear... Davis Research Institute for Medical Research at ... for the early diagnosis and treatment of Alzheime...fellows Hamid Qureshi and Yifan Lu, report that th...
...22 A woman may share genetics with her mother, bu...unpleasant menopause filled with hot flashes, inso...Solutions: Vibrant Health, Balanced Living magazi...(HRT), which increases risk of breast cancer, stro...
... anti-tumor drugs is a hot research area. Chrysin ...ted flavonoid, has been reported to have many diff...anti-virus, antidiabetogenic activity and clear an...tion. To improve the biological activity of chrysi...
...n that you can personalize. , , PITTSBURGH, May 2...vider of Computerized Maintenance Management Syste...MS OnSite Professional, a CMMS you can personalize... create their own screen layouts or designs allowi...
Other Medicine News:Health News:Feeding America Partner Support Expedites Disaster Relief and Recovery Efforts 2Health News:Alzheimer's discovery could bring early diagnosis, treatment closer 2Health News:What You Need to Know in Your 40s to Have a Healthy Menopause -- Without Hormone Replacement Therapy 2Health News:A potential drug for liver carcinoma 2Health News:Four Rivers Software System Launches TMS OnSite Professional 2
...id Medication Delivery., ,Designed for adolescent...tes an additional lumen and injection port for rap...s three endotracheal tubes designs which allow for... delivery without additional adaptors., ETCO2&trad...
SHERIDAN LTS Endotracheal Tubes
SPIRAL-FLEX® Oral Precut Reinforced Tubes
SPIRAL-FLEX® Reinforced Oral/Nasal Cuffed Endotracheal Tubes
Medicine Products: